LAERA, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 781
EU - Europa 615
AS - Asia 118
AF - Africa 1
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.518
Nazione #
US - Stati Uniti d'America 773
IE - Irlanda 146
GB - Regno Unito 135
CN - Cina 69
RU - Federazione Russa 62
UA - Ucraina 59
SE - Svezia 56
IT - Italia 34
FR - Francia 30
SG - Singapore 28
DE - Germania 23
LU - Lussemburgo 17
FI - Finlandia 15
BE - Belgio 13
ES - Italia 13
CA - Canada 8
IN - India 8
IR - Iran 4
TR - Turchia 4
CH - Svizzera 3
TH - Thailandia 3
AL - Albania 2
NO - Norvegia 2
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JP - Giappone 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
Totale 1.518
Città #
Dublin 146
Fairfield 139
Southend 125
Woodbridge 76
Ann Arbor 67
Ashburn 54
Cambridge 54
Wilmington 54
Chandler 50
Jacksonville 48
Seattle 46
Houston 37
Princeton 24
Singapore 22
Roodt-sur-Syre 14
Brussels 13
Málaga 12
Nanjing 12
New York 12
Boardman 11
San Mateo 11
Beijing 9
Siena 8
Jiaxing 7
Dallas 6
Helsinki 6
Nanchang 6
Los Angeles 5
San Diego 5
Shenyang 5
Toronto 5
Cagliari 4
Moscow 4
Shanghai 4
Taizhou 4
Hebei 3
Kunming 3
Monteroni Di Lecce 3
Redwood City 3
Venezia 3
Zanjan 3
Zhengzhou 3
Bangalore 2
Bangkok 2
Bari 2
Basel 2
Chennai 2
Dearborn 2
Düsseldorf 2
Istanbul 2
Jinan 2
London 2
Milan 2
Montreal 2
Munich 2
Ningbo 2
Oslo 2
San Carlos 2
Schifflange 2
Tirana 2
Verolanuova 2
Adliswil 1
Bengaluru 1
Caccuri 1
Changsha 1
Chianciano Terme 1
Chicoutimi 1
Dudelange 1
Fuzhou 1
Guangzhou 1
Guidonia Montecelio 1
Gwanak-gu 1
Hefei 1
Iga 1
Indiana 1
Kashan 1
Kharkov 1
Kilburn 1
Lawrence 1
Mcallen 1
Norwalk 1
Nürnberg 1
Riga 1
Samut Sakhon 1
San Jose 1
Santa Clara 1
Sofia 1
Tappahannock 1
Targu 1
Tianjin 1
Washington 1
Wood Green 1
Yingkou 1
Zgierz 1
Zibo 1
Totale 1.198
Nome #
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 155
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 154
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 150
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 137
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience 128
null 103
null 98
null 96
Metabolomics as predictive biomarker of response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) 92
null 88
Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study 86
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 60
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 47
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 45
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 41
null 39
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 34
Totale 1.553
Categoria #
all - tutte 5.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020260 0 0 0 0 17 22 41 54 53 36 15 22
2020/2021240 7 26 16 29 10 28 11 36 17 32 20 8
2021/2022168 9 13 12 9 19 8 6 5 9 20 13 45
2022/2023204 14 17 34 27 17 41 18 8 11 12 0 5
2023/2024226 12 2 18 9 2 55 87 4 2 12 16 7
2024/2025112 11 22 49 26 4 0 0 0 0 0 0 0
Totale 1.553